Publications:

Sortilin-related receptor is a druggable therapeutic target in breast cancer.

Molecular Oncology

Al-Akhrass, Hussein H; Pietilä, Mika M; Lilja, Johanna J; Vesilahti, Ella-Maria EM; Anttila, Johanna M JM; Haikala, Heidi M HM; Munne, Pauliina M PM; Klefström, Juha J; Peuhu, Emilia E; Ivaska, Johanna J

Publication Date: 2021-09-26

Variant appearance in text: HER2: P1130T

PubMed Link: 34564954

Variant Present in the following documents:

• Main text
• MOL2-16-116.pdf

View BVdb publication page

Sortilin-related receptor is a druggable therapeutic target in breast cancer.

Molecular Oncology

Al-Akhrass, Hussein H; Pietilä, Mika M; Lilja, Johanna J; Vesilahti, Ella-Maria EM; Anttila, Johanna M JM; Haikala, Heidi M HM; Munne, Pauliina M PM; Klefström, Juha J; Peuhu, Emilia E; Ivaska, Johanna J

Publication Date: 2022-01

Variant appearance in text: HER2: P1130T

PubMed Link: 34564954

Variant Present in the following documents:

• Main text
• MOL2-16-116.pdf

View BVdb publication page

Tumorigenicity-associated characteristics of human iPS cell lines.

Plos One

Yasuda, Satoshi S; Kusakawa, Shinji S; Kuroda, Takuya T; Miura, Takumi T; Tano, Keiko K; Takada, Nozomi N; Matsuyama, Satoko S; Matsuyama, Akifumi A; Nasu, Michiyo M; Umezawa, Akihiro A; Hayakawa, Takao T; Tsutsumi, Hideki H; Sato, Yoji Y

Publication Date: 2018

Variant appearance in text: ERBB2: P1130T

PubMed Link: 30286143

Variant Present in the following documents:

• pone.0205022.s006.xlsx, sheet 1

View BVdb publication page